JZP441

DRUG3 trials

Sponsors

Jazz Pharmaceuticals

Conditions

Healthy ParticipantsNarcolepsy

Phase 1

A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants

CompletedNCT05651152

Jazz PharmaceuticalsHealthy Participants

Start: 2022-11-28End: 2023-11-15Updated: 2024-07-30

A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants

CompletedNCT05720494

Jazz PharmaceuticalsHealthy Participants

Start: 2023-01-26End: 2023-09-29Updated: 2024-10-01

A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

TerminatedNCT06961266

Jazz PharmaceuticalsNarcolepsy

Start: 2025-05-13End: 2026-01-29Updated: 2026-04-06